Journal of Ovarian Research

Prohibitin 1 Interacts With p53 in the Regulation of Mitochondrial Dynamics and Chemoresistance in Gynecologic Cancers

Friday, June 10, 2022 - 9:17am
Cancer Research

Impact of Estrogen Receptor Expression on Prognosis of Ovarian Cancer According to Antibody Clone Used for Immunohistochemistry: A Meta-Analysis

Tuesday, May 24, 2022 - 8:00am

Lifetime Ovulatory Years and Ovarian Cancer Gene Expression Profiles

Friday, May 13, 2022 - 8:00am

Impact of Neoadjuvant Chemotherapy on Somatic Mutation Status in High-Grade Serous Ovarian Carcinoma

Monday, May 2, 2022 - 8:00am

High Expression of RIPK2 is Associated With Taxol Resistance in Serous Ovarian Cancer

Wednesday, April 27, 2022 - 8:00am

Peripheral Lymphocyte Populations in Ovarian Cancer Patients and Correlations With Clinicopathological Features

Monday, April 11, 2022 - 8:00am

Up-Regulation of MTHFD2 is Associated With Clinicopathological Characteristics and Poor Survival in Ovarian Cancer, Possibly by Regulating MOB1A Signaling

Tuesday, February 8, 2022 - 7:00am

Integrated Clinical Characteristics and Omics Analysis Identifies a Ferroptosis and Iron-Metabolism-Related lncRNA Signature for Predicting Prognosis and Therapeutic Responses in Ovarian Cancer

Thursday, January 20, 2022 - 7:00am

The Prognostic Factor for Recurrence in Advanced-Stage High-Grade Serous Ovarian Cancer After Complete Clinical Remission

Monday, December 20, 2021 - 7:00am

Molecular Response to PARP1 Inhibition in Ovarian Cancer Cells as Determined by Mass Spectrometry Based Proteomics

Friday, October 22, 2021 - 8:00am
Subscribe to Journal of Ovarian Research